DURAQUIN Drug Patent Profile
✉ Email this page to a colleague
When do Duraquin patents expire, and what generic alternatives are available?
Duraquin is a drug marketed by Warner Chilcott and is included in one NDA.
The generic ingredient in DURAQUIN is quinidine gluconate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the quinidine gluconate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duraquin
A generic version of DURAQUIN was approved as quinidine gluconate by SUN PHARM INDUSTRIES on February 11th, 1987.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DURAQUIN?
- What are the global sales for DURAQUIN?
- What is Average Wholesale Price for DURAQUIN?
Summary for DURAQUIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 1,734 |
| DailyMed Link: | DURAQUIN at DailyMed |
US Patents and Regulatory Information for DURAQUIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Warner Chilcott | DURAQUIN | quinidine gluconate | TABLET, EXTENDED RELEASE;ORAL | 017917-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
